Prophylactic Central Neck Dissection for Papillary Thyroid Carcinoma

Brief summary (registry, in English)

This study designed to examine the utility of prophylactic central neck dissection (CND) in the management of papillary thyroid carcinoma (PTC), to assess the association between risk factors as gender, age at diagnosis, and size of the tumor with performing central lymph node (CLN) affection, and to assess operative time, intraoperative and postoperative adverse events of CLN neck dissection.

What you commit to

• Study type: Observational
• Participants enrolled: 100
• From 1 May 2023 to the primary completion date, 1 May 2023
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Who the study is looking for

Age in the registry: 18 years to 60 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.